KOPP INVESTMENT ADVISORS LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 217 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
KOPP INVESTMENT ADVISORS LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$1,053,000
-35.3%
10,578
-25.8%
1.94%
+4.3%
Q2 2019$1,628,000
-32.5%
14,263
-25.7%
1.86%
-5.0%
Q1 2019$2,413,000
-8.0%
19,191
-0.8%
1.95%
-23.8%
Q4 2018$2,624,000
-50.9%
19,340
-0.7%
2.56%
-43.1%
Q3 2018$5,346,000
+11.5%
19,477
-15.8%
4.50%
+0.1%
Q2 2018$4,793,000
+35.6%
23,136
+8.1%
4.50%
+25.1%
Q1 2018$3,535,000
+17.2%
21,405
-2.8%
3.59%
+19.0%
Q4 2017$3,016,000
+0.5%
22,026
-0.1%
3.02%
+9.8%
Q3 2017$3,002,000
+10.3%
22,046
-1.7%
2.75%
+12.9%
Q2 2017$2,721,000
+9.1%
22,416
-4.9%
2.44%
-0.0%
Q1 2017$2,494,000
+3.2%
23,564
-0.9%
2.44%
-4.5%
Q4 2016$2,417,000
+1.0%
23,785
+1.4%
2.55%
+7.9%
Q3 2016$2,394,000
-34.0%
23,458
-22.9%
2.37%
+22.6%
Q2 2016$3,628,000
+8.8%
30,417
-2.3%
1.93%
+6.1%
Q1 2016$3,334,000
+0.8%
31,134
+2.1%
1.82%
+11.9%
Q4 2015$3,306,000
+22.5%
30,490
-3.2%
1.62%
+11.9%
Q3 2015$2,699,000
-3.9%
31,508
+13.2%
1.45%
+16.1%
Q2 2015$2,809,000
+48.7%
27,844
+13.6%
1.25%
+49.6%
Q1 2015$1,889,000
+49.6%
24,501
+3.2%
0.84%
+37.7%
Q4 2014$1,263,000
+46.3%
23,731
+29.2%
0.61%
+42.2%
Q3 2014$863,000
-26.5%
18,368
-2.5%
0.43%
-20.8%
Q2 2014$1,174,000
+248.4%
18,847
+276.0%
0.54%
+282.3%
Q1 2014$337,000
+59.7%
5,012
+25.2%
0.14%
+48.4%
Q4 2013$211,000
-88.7%
4,004
-90.7%
0.10%
-86.2%
Q3 2013$1,867,000
+1.1%
43,139
-12.6%
0.69%
-5.0%
Q2 2013$1,847,00049,3790.72%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders